I thank Deputy Roche for his question. My Department provides a range of income supports for those who are unable to work due to illness or disability, including those with rare diseases. These include non-contributory payments that are based on a needs test, such as disability allowance, but also contributory payments that are based on PRSI contributions, such as invalidity pension. Eligibility for these supports is not dependent on the type of a rare disease a person has but on the extent to which the particular condition impairs or restricts a person's capacity to work. The purpose of these payments is to provide income support for those with a condition that limits their ability to earn an income.
Rare diseases present unique challenges, and these differ from person to person. They can mean that a person is unable to work or only able to work part-time. My Department's income supports are designed to support a person to work where they can. For instance, disability allowance has an income disregard. This means a person can earn up to €527.60 and still keep a portion of their payment and the associated secondary benefits.
In addition, those who are on illness benefit for longer than six months or who are on invalidity pension can transfer to partial capacity benefit where they can work, earn unlimited income and still keep a percentage of their payment.
Under the national human rights strategy for disabled people, which was developed with significant input from disability groups and advocates, it was agreed to establish a strategic focus network summit on the cost of disability.
My Department is leading on this initiative but we also include other Government Departments in what is cross-government endeavour. It goes without saying that those who represent disabled people, disabled people themselves and their families, carers and advocates are also involved, and will play a full part in the consultation and in the summit on 13 May. I have launched a public consultation process on how a cost-of-disability payment and the strategic focus network can be best delivered, and I look forward to engaging with the Deputy and with the rare diseases group in the Oireachtas, through Deputy O'Sullivan, around supports that can be done there.